Versions Compared
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Purpose | ||||||||
The WMDA strives to achieve the best for stem cell donors and transplant patients. We developed a comprehensive strategic plan that conveys its ambition and priorities for the years 2018-2021. As an organisation that exists to achieve the best for stem cell donors and transplant patients, the strategy has been co-created with affiliate their member organisations so that it will support them to harness opportunities and mitigate risks in the medium-term. The strategy aims to deliver impact in the following areas:
This strategy has been informed by the objectives of the EU Third Health Programme; EU’s analysis of the economic landscape; results of the joint action ARTHIQS, and European data In Since 2018, WMDA was is funded a by the EU Third Health Programme. The 2018 project includes 13 2020 work programme includes 11 Deliverables that were submitted to and approved by the European Commission. | ||||||||
Projects | ||||||||
---|---|---|---|---|---|---|---|---|
2021
2020
| ||||||||
2019
| ||||||||
2018
|
The EU Health Programme | ||
What is the Health Programme?The Health Programme is a funding instrument to support cooperation among EU countries and underpin and develop EU health activities. The legal basis for the Health Programme is agreed with the European Parliament and the Council for a period of several years. Third Health Programme (2014-2020)Regulation (EU) 282/2014 is the legal basis for the current Health Programme. With a budget of €449.4 million and throughout 23 priority areas, the Health Programme serves four specific objectives:
| ||
---|---|---|
Space Administrator
user | former.wmda.staff2 | |
Helpful Links
|